High Blood Pressure - Nursing Case Study

Pathophysiology

• Primary mechanism: Increased peripheral vascular resistance due to narrowing of blood vessels, often caused by endothelial dysfunction, leads to higher systolic and diastolic blood pressure. This is primarily influenced by factors like vasoconstrictors (e.g., angiotensin II) which cause blood vessels to tighten.

• Secondary mechanism: Enhanced sodium retention in the kidneys increases blood volume, contributing to elevated blood pressure. This process is often mediated by an overactive renin-angiotensin-aldosterone system (RAAS), which promotes sodium and water retention.

• Key complication: Chronic high blood pressure can lead to target organ damage, such as hypertensive heart disease, characterized by left ventricular hypertrophy, which can compromise cardiac function over time.

Patient Profile

Demographics:

56-year-old male, construction worker

History:

• Key past medical history: Hypertension diagnosed 5 years ago, borderline type 2 diabetes, family history of cardiovascular disease

• Current medications: Lisinopril 20 mg once daily, Metformin 500 mg twice daily, Aspirin 81 mg once daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent headache and dizziness

• Key symptoms: Fatigue, shortness of breath on exertion, occasional chest discomfort

• Vital signs: Blood pressure 160/100 mmHg, heart rate 92 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F, SpO2 95% on room air

Section 1

New Diagnostic Results:

Following the initial assessment, the healthcare team decided to conduct several diagnostic tests to better understand the underlying causes of the patient's symptoms and the current state of his hypertension. An electrocardiogram (ECG) was performed, revealing signs of left ventricular hypertrophy, a common consequence of chronic high blood pressure. This finding suggests that the heart has been working harder to pump blood against the increased vascular resistance, leading to thickening of the heart muscle. Blood tests were also ordered, which highlighted an elevated serum creatinine level of 1.6 mg/dL, indicating possible renal impairment. The blood glucose level was recorded at 145 mg/dL, slightly above the normal range, indicating suboptimal control of his borderline type 2 diabetes.

Additionally, a chest X-ray showed mild cardiomegaly, further supporting the presence of cardiac changes due to sustained hypertension. A renal ultrasound was conducted, which revealed no significant structural abnormalities but suggested decreased renal perfusion, potentially linked to the patient's high blood pressure and compromised kidney function. These diagnostic results emphasize the need for more aggressive management of his hypertension and diabetes to prevent further target organ damage and highlight the interconnectedness of these conditions.

The new findings underscore the importance of optimizing the patient's treatment plan to address both the cardiovascular and renal aspects of his condition. Adjustments in medication, such as increasing the dose of Lisinopril or adding another antihypertensive agent, may be necessary to achieve better blood pressure control. In parallel, reinforcing lifestyle modifications, such as dietary changes and regular physical activity, along with more stringent monitoring of blood glucose levels, will be critical in managing the patient's overall health and preventing further complications.

Section 2

Change in Patient Status:

As the healthcare team implemented modifications to the patient's treatment plan, including an increased dose of Lisinopril and the introduction of a low-dose thiazide diuretic, initial improvements in blood pressure were observed. However, during a follow-up visit two weeks later, the patient reported episodes of dizziness and lightheadedness, particularly when standing up quickly. Vital signs revealed a blood pressure of 115/70 mmHg, indicating a significant drop from previous readings, and a heart rate of 92 beats per minute, slightly elevated from baseline. Orthostatic hypotension was suspected, likely a result of the recent medication adjustments.

Additionally, the patient expressed concerns about increased frequency of nocturia and mild fatigue, raising suspicions of potential side effects from the diuretic therapy. Blood tests were repeated, showing a further rise in serum creatinine to 1.8 mg/dL, suggesting that the kidneys were still under strain despite the initial efforts to optimize the treatment plan. Electrolyte levels remained within normal limits, but closer monitoring was advised to prevent potential imbalances. The patient’s blood glucose level had also increased to 150 mg/dL, highlighting the need for a more comprehensive approach to diabetes management alongside hypertension control.

These developments prompted the healthcare team to reassess the current medication regimen, considering the possibility of adjusting the diuretic dose or switching to an alternative antihypertensive agent with a more favorable side effect profile. The importance of gradual position changes was emphasized to manage orthostatic symptoms. Furthermore, the team explored non-pharmacological strategies to support renal function, such as increased fluid intake and dietary modifications, while continuing to monitor the patient's cardiovascular and renal status closely. This phase of the patient's journey underscores the complexity of managing comorbid conditions and the necessity for ongoing clinical reasoning to fine-tune treatment strategies effectively.

Section 3

In the following weeks, the patient's condition presented new challenges, as the healthcare team continued to adjust the treatment plan. Despite the initial measures, the patient returned with new complaints of increased fatigue, muscle cramps, and a mild but persistent headache. A detailed assessment revealed a blood pressure of 110/68 mmHg, further indicating a trend toward hypotension. The heart rate remained slightly elevated at 96 beats per minute. The patient’s weight had decreased by three pounds, which was unintentional, pointing to possible dehydration or inadequate nutritional intake as a result of the diuretic therapy.

Given these symptoms, the healthcare team ordered additional blood tests to evaluate possible electrolyte imbalances that might be contributing to the muscle cramps and fatigue. The results showed a mild hyponatremia with sodium levels at 133 mEq/L, slightly below the normal range, and a slight decrease in potassium levels to 3.4 mEq/L. These findings suggested that the thiazide diuretic might be causing electrolyte depletion, necessitating an adjustment in the medication regimen. Additionally, the serum creatinine level had risen further to 2.0 mg/dL, reinforcing concerns about the patient's renal function under the current treatment plan.

Recognizing the need for a more tailored approach, the healthcare team decided to reduce the dose of the thiazide diuretic and considered substituting it with a potassium-sparing diuretic to address the electrolyte imbalances. Furthermore, they emphasized the importance of adequate hydration and recommended an individualized dietary plan to ensure proper nutrition and support renal function. The patient was also educated about recognizing signs of dehydration and encouraged to report any new or worsening symptoms promptly. These steps aimed to stabilize the patient's condition and prevent further complications, guiding the next phase of managing the intricate balance of hypertension, renal function, and overall well-being.

Section 4

In the following days, the patient returned for a follow-up visit, and a comprehensive assessment was conducted to evaluate the response to the adjusted treatment plan. The patient reported feeling slightly more energized, and the frequency of muscle cramps had decreased. However, the headache persisted, albeit less pronounced than before. Upon examination, the patient's blood pressure was recorded at 118/72 mmHg, indicating a slight improvement from the previous hypotensive trend. The heart rate remained stable at 92 beats per minute. Importantly, the patient's weight had stabilized, suggesting better hydration and nutritional intake.

New blood tests were ordered to monitor the impact of the medication adjustments. The results showed improvements: sodium levels had increased to 136 mEq/L, approaching the normal range, and potassium levels had risen to 3.8 mEq/L, indicating a positive response to the potassium-sparing diuretic. Despite these improvements, serum creatinine remained elevated at 1.9 mg/dL, signaling ongoing concern for renal function. The healthcare team considered these findings reflective of a cautiously optimistic trend but remained vigilant about renal health.

Anticipating potential challenges, the team decided to continue monitoring renal function closely while maintaining the current medication regimen. They also reinforced the importance of dietary adjustments, emphasizing foods rich in potassium and hydration to support kidney health. The patient was scheduled for another follow-up in two weeks, with instructions to keep a detailed log of symptoms and dietary intake. This strategic approach aimed to sustain progress while guarding against new complications, setting the stage for continual assessment and adaptation in managing this complex case.

Section 5

Two weeks later, the patient returned for the scheduled follow-up visit, and new diagnostic results were available. The blood pressure remained stable at 120/75 mmHg, and the heart rate was consistent at 90 beats per minute. However, the patient reported experiencing intermittent episodes of lightheadedness, particularly when standing quickly, and occasional palpitations. Despite these symptoms, the patient felt generally better and had noted an improvement in energy levels.

The updated lab tests painted a nuanced picture of the patient's condition. While sodium levels were within the normal range at 138 mEq/L, and potassium had stabilized at 4.0 mEq/L, the serum creatinine had slightly increased to 2.1 mg/dL. This uptick in creatinine raised concerns about the potential progression of renal impairment. In addition, the blood urea nitrogen (BUN) was noted to be elevated at 28 mg/dL, further suggesting stress on the kidneys. The healthcare team considered the possibility that the ongoing use of the potassium-sparing diuretic, while beneficial for electrolyte balance, might be contributing to renal strain.

In response to these findings, the team decided to adjust the treatment plan. They opted to reduce the dosage of the current diuretic and introduce an ACE inhibitor to better manage both blood pressure and renal function. The patient was advised to continue dietary modifications, focusing on moderate protein intake to alleviate renal workload, and to maintain hydration. These changes were explained to the patient with an emphasis on the importance of adherence and monitoring, as the team aimed to optimize blood pressure control while safeguarding kidney health. The patient was scheduled for another follow-up in four weeks, with a plan to reassess renal function and overall response to the revised treatment regimen, ensuring that any new complications could be addressed promptly.